Antioxidants and neonatal lung disease

Area of Science:

• Neonatal Medicine
• Biochemistry
• Pulmonary Medicine

Background:

• Bronchopulmonary dysplasia (BPD) is a persistent challenge in neonatal intensive care survivors.
• Oxygen toxicity and an imbalance in the oxidant-antioxidant system are implicated in BPD pathogenesis.
• Preterm infants exhibit insufficient antioxidant potential, making them vulnerable to oxidant stress at birth.

Purpose of the Study:

• To explore the role of oxidant-antioxidant imbalance in BPD pathogenesis.
• To investigate potential therapeutic strategies for managing BPD in preterm infants.

Main Methods:

• Review of existing literature on BPD, oxygen toxicity, and antioxidant mechanisms.
• Analysis of the biochemical challenges in preterm neonates regarding oxidant stress.
• Examination of the effects of antenatal steroid therapy on pulmonary antioxidants and surfactant.

Main Results:

• Preterm infants are susceptible to significant oxidant stress due to inadequate antioxidant defenses.
• Antenatal steroid administration has demonstrated potential in augmenting pulmonary antioxidants and surfactant production.
• Exogenous antioxidant enzyme administration (e.g., superoxide dismutase, catalase) shows promise in animal models.

Conclusions:

• Addressing the oxidant-antioxidant imbalance is crucial for managing preterm infants at risk for BPD.
• Antenatal steroid therapy presents a promising approach to ameliorate this imbalance.
• Further clinical research is needed to evaluate the efficacy of exogenous antioxidant therapies in humans.